YU2397A - 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining - Google Patents

2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Info

Publication number
YU2397A
YU2397A YU2397A YU2397A YU2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A
Authority
YU
Yugoslavia
Prior art keywords
phenyl
aroylbenzothiophenes
medicaments
obtaining
hexamethyleneimino
Prior art date
Application number
YU2397A
Other languages
English (en)
Serbo-Croatian (sh)
Serbian (sr)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Eli Lilly Company
Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly Company, Lilly Corporate Center filed Critical Eli Lilly Company
Publication of YU2397A publication Critical patent/YU2397A/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
YU2397A 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining YU2397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
YU2397A true YU2397A (en) 1999-11-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2397A YU2397A (en) 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Country Status (19)

Country Link
EP (1) EP0921799A4 (id)
JP (1) JP2000503994A (id)
KR (1) KR19990082054A (id)
CN (1) CN1209745A (id)
AR (1) AR010978A1 (id)
AU (1) AU707892B2 (id)
BR (1) BR9700778A (id)
CO (1) CO4761062A1 (id)
CZ (1) CZ235498A3 (id)
EA (1) EA001104B1 (id)
ID (1) ID15917A (id)
IL (1) IL125521A (id)
MX (1) MX9806036A (id)
NO (1) NO983451L (id)
NZ (1) NZ331105A (id)
PL (1) PL328147A1 (id)
TW (1) TW446560B (id)
WO (1) WO1997026877A1 (id)
YU (1) YU2397A (id)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
DK0652004T3 (da) * 1993-10-15 2002-09-02 Lilly Co Eli Fremgangsmåder til behandling af resistente neoplasmer
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
CZ235498A3 (cs) 1999-02-17
IL125521A (en) 2001-11-25
MX9806036A (es) 1998-11-29
NZ331105A (en) 2000-06-23
AR010978A1 (es) 2000-08-02
CO4761062A1 (es) 1999-04-27
JP2000503994A (ja) 2000-04-04
EP0921799A4 (en) 2002-03-13
EA001104B1 (ru) 2000-10-30
EA199800677A1 (ru) 1999-02-25
NO983451D0 (no) 1998-07-27
WO1997026877A1 (en) 1997-07-31
PL328147A1 (en) 1999-01-18
IL125521A0 (en) 1999-03-12
EP0921799A1 (en) 1999-06-16
TW446560B (en) 2001-07-21
ID15917A (id) 1997-08-21
CN1209745A (zh) 1999-03-03
AU2123997A (en) 1997-08-20
NO983451L (no) 1998-07-27
AU707892B2 (en) 1999-07-22
KR19990082054A (ko) 1999-11-15
BR9700778A (pt) 1998-10-06

Similar Documents

Publication Publication Date Title
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
LU91497I2 (fr) Rivaroxaban et ses sels pharmaceutiquement acceptables,hydrates,hydrates de ces sels et promédicaments
YU69902A (sh) Novi derivati piperazina
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
NO944930D0 (no) Hemming av dysfunksjonell uterin blödning
UA39941C2 (uk) Засіб для інгібування окислення ліпопротеїну низької щільності, засіб для приглушення атеросклерозу та засіб для приглушення ішемічної хвороби серця атеросклеротичного походження
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
DK0659411T3 (da) Fremgangsmåde til forøgelse af libido hos kvinder efter menopausen
HRP20000585B1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
DK0659413T3 (da) Inhibering af CNS-problemer hos postmenopausale kvinder
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
EA199800015A1 (ru) Способ ингибирования меланомы
TR199802456T2 (xx) Yeni pirol t�revleri.
YU2397A (en) 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining
YU55495A (sh) Upotreba benzotiofena za dobijanje leka
MX9701333A (es) Metodos para inhibir el daño neuronal.
MY113757A (en) Methods of inhibiting endometrial cancer
ATE220905T1 (de) Benzo(b)thiophene derivaten zur verringerung der blutplätchenzahl